Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Occurrence of atypical HUS associated with influenza B

Abstract

Hemolytic uremic syndrome (HUS) is a disease characterized by thrombotic microangiopathy with a triad of non-immune hemolytic anemia, thrombocytopenia, and renal impairment. Approximately 10% of cases of HUS are classified as atypical (aHUS). While today many genetically forms of aHUS pathology are known, only about 50% of carriers precipitate the disease. The reason remains unclear, and triggering events like intercurrent infections have been postulated. In rare cases, influenza A is the known trigger of aHUS; however, no cases of influenza B have been reported.

Conclusion: We describe for the first time that influenza B strain as a trigger for aHUS in children with primary hereditary forms. We also showed in our three cases that immunization appears to be safe; however, this needs to be confirmed in a larger cohort.

What is Known:
• Known triggers of aHUS are infectious specimen.
• Influenza A-associated aHUS cases are rarely published.
What is New:
• aHUS can be triggered by influenza B virus infection.
• Influenza vaccination of patients with aHUS appears safe.

This is a preview of subscription content, log in to check access.

Abbreviations

aHUS:

Atypical hemolytic uremic syndrome

CFH:

Complement factor H

eGFR:

Estimated glomerular filtration rate

EHEC:

Enterohemorragische Escherichia coli

HUS:

Hemolytic uremic syndrome

MCP:

Membrane cofactor protein

TTP:

Thrombotic thrombocytopenic purpura

References

  1. 1.

    Scheiring J, Rosales A, Zimmerhackl LB (2010) Clinical practice. Today’s understanding of the haemolytic uraemic syndrome. Eur J Pediatr 169(1):7–13

  2. 2.

    Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC (2012) A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med 70(3):121–129

  3. 3.

    Watanabe T (2013) Renal complications of seasonal and pandemic influenza A virus infections. Eur J Pediatr 172(1):15–22

  4. 4.

    Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, Bigot S, Hue C, Satchell SC, Mathieson PW, Mousson C, Noel C, Sautes-Fridman C, Halbwachs-Mecarelli L, Atkinson JP, Lionet A, Fremeaux-Bacchi V (2012) A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 119(18):4182–4191

  5. 5.

    Ståhl AL, Kristoffersson A, Olin AI, Olsson ML, Roodhooft AM, Proesmans W, Karpman D (2009) A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome. Mol Immunol 46(11–12):2236–2243

  6. 6.

    Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L (2012) Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding. Pediatr Nephrol 27(9):1519–1524

  7. 7.

    Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP (2006) Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 17(7):2017–2025

  8. 8.

    Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Müslümanoğlu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 100(22):12966–12971

  9. 9.

    Geerdink LM1, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Kömhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC (2012) Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics. Pediatr Nephrol 27(8):1283–1291

  10. 10.

    Fan X, Yoshida Y, Honda S, Matsumoto M, Sawada Y, Hattori M, Hisanaga S, Hiwa R, Nakamura F, Tomomori M, Miyagawa S, Fujimaru R, Yamada H, Sawai T, Ikeda Y, Iwata N, Uemura O, Matsukuma E, Aizawa Y, Harada H, Wada H, Ishikawa E, Ashida A, Nangaku M, Miyata T, Fujimura Y (2013) Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Mol Immunol 54(2):238–246

  11. 11.

    Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, AMD Genetics Clinical Study Group, Hageman GS, Dean M, Allikmets R (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38(4):458–462

  12. 12.

    Joseph C, Gattineni J (2013) Complement disorders and hemolytic uremic syndrome. Curr Opin Pediatr 25(2):209–215

  13. 13.

    Salvadori M, Bertoni E (2013) Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations. World J Nephrol 2(3):56–76

  14. 14.

    Lee MH, Cho KS, Kahng KW, Kang CM (1998) A case of hemolytic uremic syndrome associated with Epstein-Barr virus infection. Korean J Intern Med 13(2):131–135

  15. 15.

    Spinale JM, Ruebner RL, Kaplan BS, Copelovitch L (2013) Update on Streptococcus pneumoniae associated hemolytic uremic syndrome. Curr Opin Pediatr 25(2):203–208

  16. 16.

    Kwon T, Belot A, Ranchin B, Baudouin V, Fremeaux-Bacchi V, Dragon-Durey MA, Cochat P, Loirat C (2009) Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases. Nephrol Dial Transplant 24(9):2752–2754

  17. 17.

    Burke PA Jr, Aljadir D, Raman T (2010) Diagnosis, management, and pathogenesis of TTP/HUS in an HIV positive patient. Del Med J 82(9):309–312

  18. 18.

    Allen U, Licht C (2011) Pandemic H1N1 influenza A infection and (atypical) HUS—more than just another trigger? Pediatr Nephrol 26(1):3–5

  19. 19.

    Lei TH, Hsia SH, Wu CT, Lin JJ (2010) Streptococcus pneumoniae-associated haemolytic uremic syndrome following influenza A virus infection. Eur J Pediatr 169(2):237–239

  20. 20.

    Pettilä V, Webb SA, Bailey M, Howe B, Seppelt IM, Bellomo R (2011) Acute kidney injury in patients with influenza A (H1N1) 2009. Intensive Care Med 37(5):763–767

  21. 21.

    Watanabe T (2001) Hemolytic uremic syndrome associated with influenza A virus infection. Nephron 89(3):359–360

  22. 22.

    Asaka M, Ishikawa I, Nakazawa T, Tomosugi N, Yuri T, Suzuki K (2000) Hemolytic uremic syndrome associated with influenza A virus infection in an adult renal allograft recipient: case report and review of the literature. Nephron 84(3):258–266

  23. 23.

    Petersen VP, Olsen TS (1971) Late renal transplant failure due to the hemolytic-uremic syndrome. Acta Med Scand 189:377–380

  24. 24.

    Claude D, Delorme N, Schooneman F, Laprevote-Heully MC, Lambert H, Larcan A (1984) Hemolytic-uremic syndrome of viral origin successfully treated by plasma exchange. Presse Med 13(16):1003–1004

  25. 25.

    Davison AM, Thomson D, Robson JS (1973) Intravascular coagulation complicating influenza A virus infection. Brit Med J 1:654–655

  26. 26.

    Fortin MC, Raymond MA, Madore F, Fugère JA, Pâquet M, St-Louis G, Hébert MJ (2004) Increased risk of thrombotic microangiopathy in patients receiving cyclosporine-sirolimus combination. Am J Transplant 4:946–952

  27. 27.

    Caltik A, Akyüz SG, Erdogan O, Demircin G (2011) Hemolytic uremic syndrome triggered with a new pandemic virus: influenza A (H1N1). Pediatr Nephrol 26(1):147–148

  28. 28.

    Al-Akash SI, Almond PS, Savell VH Jr, Gharaybeh SI, Hogue C (2011) Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. Pediatr Nephrol 26(4):613–619

  29. 29.

    Rhee H, Song SH, Lee YJ, Choi HJ, Ahn JH, Seong EY, Lee SB, Kwak IS (2011) Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage. Clin Exp Nephrol 15(6):948–952

  30. 30.

    Bento D, Mapril J, Rocha C, Marchbank KJ, Kavanagh D, Barge D, Strain L, Goodship TH, Meneses-Oliveira C (2010) Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1). Ren Fail 32(6):753–756

  31. 31.

    Golubovic E, Miljkovic P, Zivic S, Jovancic D, Kostic G (2011) Hemolytic uremic syndrome associated with novel influenza A H1N1 infection. Pediatr Nephrol 26(1):149–150

  32. 32.

    Printza N, Roilides E, Kotsiou M, Zafeiriou D, Hatzidimitriou V, Papachristou F (2011) Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome. Pediatr Nephrol 26(1):143–144

  33. 33.

    Trachtman H, Sethna C, Epstein R, D’Souza M, Rubin LG, Ginocchio CC (2011) Atypical hemolytic uremic syndrome associated with H1N1 influenza A virus infection. Pediatr Nephrol 26(1):145–146

  34. 34.

    Huang RT, Dietsch E, Rott R (1985) Further studies on the role of neuraminidase and the mechanism of low pH dependence in influenza virus-induced membrane fusion. J Gen Virol 66(Pt 2):295–301

  35. 35.

    Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW (2004) Pneumococcus-induced T antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 19:317–321

  36. 36.

    Superior Health Council Vaccination against seasonal flu (winter 2013–2014) http://www.health.belgium.be/internet2Prd/groups/public/@public/@shc/documents/ie2divers/19088802.pdf. Accessed 04 Jun 2014

  37. 37.

    Centers for Disease Control and Prevention http://www.cdc.gov/flu/professionals/acip/2013-summary-recommendations.htm

  38. 38.

    Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, Komada Y, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Fujimura Y, Ikejiri M, Wada H, Miyata T (2014) Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation. Int J Hematol 100(5):437–442

Download references

Authors’ contributions

Karen van Hoeve: Dr. van Hoeve is the first author and designed the study, drafted the initial manuscript, and approved the final manuscript as submitted.

Corine Vandermeulen: Prof Vandermeulen was the advisor regarding the flu vaccination of subjects and therefore acquisition of data. She provided input and feedback on the manuscript and approved the final manuscript as submitted.

Marc Van Ranst: Prof Van Ranst supervised virology data collection and approved the final manuscript as submitted.

Elena Levtchenko: Dr. Levchenko reviewed and revised the manuscript, and approved the final manuscript as submitted.

Lambert van den Heuvel: Mr. van den Heuvel analyzed and interpreted the genetic data and approved the final manuscript as submitted.

Djalila Mekahli: Dr. Mekahli conceptualized the study and approved the final manuscript as submitted.

Author information

Correspondence to Karen van Hoeve.

Ethics declarations

The manuscript has not been submitted to more than one journal for simultaneous consideration. The article has not been published previously. All authors have materially participated in the research and/or article preparation. All authors have approved the final article.

Funding

All authors acknowledge receiving no funding for this work from any organization, nor any sources of support, including pharmaceutical and industry support.

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Communicated by Mario Bianchetti

Electronic supplementary material

Figure S1

Evolution of the hematological testing during hospitalization. - X-axis: time of hospitalization (day). Day 0: time of hospitalization. - Y-axis: Blood results of hemoglubin, platelet count, creatinine level, haptoglobin, LDH and total bilirubine. - Curve: full line (▬) Patient 1, dashed line (- -) Patient 2 and dotted line (…) Patient 3. - Cut off reference value (blue line) (PDF 226 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

van Hoeve, K., Vandermeulen, C., Van Ranst, M. et al. Occurrence of atypical HUS associated with influenza B. Eur J Pediatr 176, 449–454 (2017). https://doi.org/10.1007/s00431-017-2856-5

Download citation

Keywords

  • Atypical hemolytic uremic syndrome
  • Hemolytic uremic syndrome
  • Influenza B
  • Vaccination